Across TCGA patient cohorts, LINC01825 RNA expression is significantly associated with the RNA expression of many other genes, with 12,481 significant associations in total. DLBC shows the largest number of these associations.

The most reproducible LINC01825-associated genes across cancer lineages are TRIM34, SAMD9L, and SLC39A10. Each is linked with LINC01825 in more than 21 cancer types. Because this analysis shows association rather than direction, both LINC01825-to-partner and partner-to-LINC01825 results are reported.

Each partner links to its own Q-omics profile.

RNA expression associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (LINC01825→partner) and Y-score (partner→LINC01825) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
DLBC	TRIM34 →	+0.567	+0.236	<.001	<.001	3	22
DLBC	SAMD9L →	+1.844	+0.263	<.001	<.001	3	22
DLBC	SLC39A10 →	+1.114	+0.280	<.001	<.001	3	21
THYM	RAB8B →	+0.844	+0.731	<.001	<.001	3	21
SKCM	TRIM22 →	+1.301	+0.102	<.001	<.001	3	20
DLBC	GPR174 →	+1.850	+0.232	<.001	<.001	3	20

Each partner links to its Q-omics profile. Showing the 6 strongest of 12,481 associations by consensus.

Exploration

LINC01825 survival (RNA) · tumor vs normal (RNA) · all LINC01825 data types